WASHINGTON — The Supreme Court docket on Wednesday sided with hospitals in a authorized dispute over the Trump administration’s Medicare pay cuts for discounted medication.
The case was a extremely technical dispute over how the Division of Well being and Human Providers units Medicare pay charges for pharmaceuticals. The lawsuit was over the 340B drug low cost program, which permits some hospitals and different suppliers that serve sufficient low-income sufferers to purchase discounted pharmaceuticals and use the financial savings to assist cowl different prices.
Unlock this text by subscribing to STAT+ and luxuriate in your first 30 days free!
